Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host Radiation Oncologist, Dr. Ravi Patel, MD, PhD. Ravi is Director of Radiopharmaceuticals at UPMC Hillman Cancer Center and a translational researcher at the University of Pittsburgh Department of Radiation Oncology. We discuss the emerging treatment strategy of radiopharmaceuticals (RPT), a.k.a. theranostics! We first review what these th...
All content for Oncology Unscripted is the property of Katie Coleman, Julie Johnson, Matt Spraker and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host Radiation Oncologist, Dr. Ravi Patel, MD, PhD. Ravi is Director of Radiopharmaceuticals at UPMC Hillman Cancer Center and a translational researcher at the University of Pittsburgh Department of Radiation Oncology. We discuss the emerging treatment strategy of radiopharmaceuticals (RPT), a.k.a. theranostics! We first review what these th...
Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host radiologist Dr. Costa Raptis, MD. We start by discussing the process of acquiring and interpreting radiographic images. What happens after you get your scan, and how do radiologists read them and generate reports? Also, how can patients know they are getting the right type of scan? We review some details of CT, MRI, and PET/CT scans.&n...
Oncology Unscripted
Send us a text On this episode of Oncology Unscripted, patient advocates Julie Johnson and Katie Coleman and radiation oncologist Dr. Matt Spraker host Radiation Oncologist, Dr. Ravi Patel, MD, PhD. Ravi is Director of Radiopharmaceuticals at UPMC Hillman Cancer Center and a translational researcher at the University of Pittsburgh Department of Radiation Oncology. We discuss the emerging treatment strategy of radiopharmaceuticals (RPT), a.k.a. theranostics! We first review what these th...
